Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04645134 · ClinicalTrials.gov registry record
Physical Activity and Cognitive Function in Older Adults: A Novel Role for GPLD1
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 25
- Enrollment target
NCT04645134 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 25 participants.
The verdict
NCT04645134 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The investigators are conducting a cross-sectional, observational study to investigate whether plasma GPLD1 concentrations are associated with higher cognitive function and better brain structure and function in two groups of older adults with high or low levels of physical activity.
Interventions
- BEHAVIORAL Brain Health Assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2022-03-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04645134
The ClinicalTrials.gov registry entry for NCT04645134 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brain Health Assessments is the first listed.
NCT04645134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04645134 about?
NCT04645134 is a clinical study titled "Physical Activity and Cognitive Function in Older Adults: A Novel Role for GPLD1". The investigators are conducting a cross-sectional, observational study to investigate whether plasma GPLD1 concentrations are associated with higher cognitive function and better brain structure and function in two groups of older adults with high or low levels of physical activity.
What is the current status of trial NCT04645134?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2021-04-01. Estimated completion is 2022-03-17.
What interventions are being tested in trial NCT04645134?
The interventions under investigation include: Brain Health Assessments (BEHAVIORAL).
Who is sponsoring clinical trial NCT04645134?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.